Grace Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $79.1M
Liabilities Breakdown FY2023
Total Liabilities: $11.2M
Asset Breakdown
Total Assets: $79.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $27.9M | 35.2% |
| Accounts Receivable | $802.0K | 1.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $104.0K | 0.1% |
| Goodwill | $8.1M | 10.3% |
| Intangible Assets | $41.1M | 52.0% |
| Other Assets | $1.1M | 1.4% |
Liabilities Breakdown
Total Liabilities: $11.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 11.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $9.9M | 88.9% |